应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
09995 荣昌生物
未开盘 01-06 16:08:15
81.200
+1.700
+2.14%
最高
81.550
最低
78.650
成交量
316.04万
今开
79.950
昨收
79.500
日振幅
3.65%
总市值
457.65亿
流通市值
169.37亿
总股本
5.64亿
成交额
2.54亿
换手率
1.52%
流通股本
2.09亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
荣昌生物(09995)截至12月末尚未开始股份回购
智通财经 · 01-05 19:31
荣昌生物(09995)截至12月末尚未开始股份回购
科网股分化,快手涨超11%,汽车股下挫,蔚来跌近6%
21世纪经济报道 · 01-05 17:18
科网股分化,快手涨超11%,汽车股下挫,蔚来跌近6%
港股荣昌生物午后涨近8%
每日经济新闻 · 01-05 15:06
港股荣昌生物午后涨近8%
港股异动 | 荣昌生物(09995)午后涨近8% 维迪西妥单抗新适应症拟纳入突破性疗法
智通财经 · 01-05 14:50
港股异动 | 荣昌生物(09995)午后涨近8% 维迪西妥单抗新适应症拟纳入突破性疗法
每日卖空追踪 | 荣昌生物 01月02日卖空量成交1.3万股,卖空比例为2.16%
市场透视 · 01-02
每日卖空追踪 | 荣昌生物 01月02日卖空量成交1.3万股,卖空比例为2.16%
跨国药企疯抢中国创新药
21世纪经济报道 · 01-02
跨国药企疯抢中国创新药
荣昌生物(688331)披露2022年及2023年A股限制性股票激励计划归属条件成就公告,12月29日股价下跌0.48%
证券之星 · 2025-12-29
荣昌生物(688331)披露2022年及2023年A股限制性股票激励计划归属条件成就公告,12月29日股价下跌0.48%
每日卖空追踪 | 荣昌生物 12月29日卖空量成交3.3万股,卖空比例为1.08%
市场透视 · 2025-12-29
每日卖空追踪 | 荣昌生物 12月29日卖空量成交3.3万股,卖空比例为1.08%
每周股票复盘:荣昌生物(688331)拟回购2000万至4000万元股份
证券之星 · 2025-12-28
每周股票复盘:荣昌生物(688331)拟回购2000万至4000万元股份
光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事
时代周报 · 2025-12-25
光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事
荣昌生物(09995.HK)涨超3%
每日经济新闻 · 2025-12-23
荣昌生物(09995.HK)涨超3%
港股异动 | 荣昌生物(09995)涨超3% 自研RC148实现双路径突破 机构看好后续临床潜力
智通财经 · 2025-12-23
港股异动 | 荣昌生物(09995)涨超3% 自研RC148实现双路径突破 机构看好后续临床潜力
荣昌生物拟回购 金额2000万元至4000万元
财中社 · 2025-12-22
荣昌生物拟回购 金额2000万元至4000万元
医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续
金吾财讯 · 2025-12-19
医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续
荣昌生物:关于取得金融机构股票回购专项贷款承诺函的公告
证券日报 · 2025-12-18
荣昌生物:关于取得金融机构股票回购专项贷款承诺函的公告
每日卖空追踪 | 荣昌生物 12月18日卖空量成交4.55万股,卖空比例为3.41%
市场透视 · 2025-12-18
每日卖空追踪 | 荣昌生物 12月18日卖空量成交4.55万股,卖空比例为3.41%
荣昌生物12月17日主力净流入640.3万元 散户资金抛售
市场透视 · 2025-12-17
荣昌生物12月17日主力净流入640.3万元 散户资金抛售
荣昌生物:第二届董事会第三十二次会议决议公告
证券日报 · 2025-12-15
荣昌生物:第二届董事会第三十二次会议决议公告
荣昌生物(688331.SH)拟以2000万元至4000万元回购股份
智通财经 · 2025-12-15
荣昌生物(688331.SH)拟以2000万元至4000万元回购股份
恒生医疗保健指数跌幅扩大至2.75% 医药股普遍走低 科伦博泰生物(06990)跌超7%
金吾财讯 · 2025-12-15
恒生医疗保健指数跌幅扩大至2.75% 医药股普遍走低 科伦博泰生物(06990)跌超7%
加载更多
公司概况
公司名称:
荣昌生物
所属市场:
SEHK
上市日期:
--
主营业务:
荣昌生物制药(烟台)股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":81.2,"timestamp":1767686895006,"preClose":79.5,"halted":0,"volume":3160422,"delay":0,"floatShares":208581239,"shares":563608243,"eps":-3.0459338348675296,"marketStatus":"未开盘","change":1.7,"latestTime":"01-06 16:08:15","open":79.95,"high":81.55,"low":78.65,"amount":253730419,"amplitude":0.036478,"askPrice":81.2,"askSize":1500,"bidPrice":81.15,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-1.9471717795897387,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767749400000},"marketStatusCode":0,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":79.5,"openAndCloseTimeList":[[1767663000000,1767672000000],[1767675600000,1767686400000]],"volumeRatio":0.805777,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":82.1,"timestamp":1767682800000,"preClose":81.35,"halted":0,"volume":5907900,"delay":0,"premium":"-11.35"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"2601832648","title":"荣昌生物(09995)截至12月末尚未开始股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2601832648","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601832648?lang=zh_cn&edition=full","pubTime":"2026-01-05 19:31","pubTimestamp":1767612664,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荣昌生物(09995)发布公告,截至2025年12月31日,公司尚未开始股份回购。公司将在回购期限内根据市场情况择机实施回购,并根据回购股份事项进展情况及时履行信息披露义务,上述回购进展符合法律法规的规定及公司回购方案的要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","BK1574","LU2488822045.USD","LU2328871848.SGD","LU2148510915.USD","09995","BK0239","LU1064130708.USD","LU1064131003.USD","BK1583","BK1161","688331"],"gpt_icon":0},{"id":"2601002347","title":"科网股分化,快手涨超11%,汽车股下挫,蔚来跌近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601002347","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601002347?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:18","pubTimestamp":1767604739,"startTime":"0","endTime":"0","summary":"继上周五大涨迎来开门红后,港股三大指数今日呈现窄幅震荡行情,截至收盘,恒生指数微幅上涨0.03%,国企指数跌0.22%,恒生科技指数微涨0.09%。科网股走势分化,快手涨超11%,哔哩哔哩涨超4%,阿里巴巴涨超2%,网易、小米跌超2%。港股汽车股跌幅居前,蔚来跌近6%,小鹏汽车跌超4%、零跑汽车跌超3%,长城汽车跌超6%。生物医药股涨幅居前,荣昌生物涨超7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608889219.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608889219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4504","LU0348766576.USD","BK1615","BK4531","EVS.SI","LU0348767384.USD","09866","BK1095","BK1610","LU0211977185.USD","BK1575","01024","688331","BK4574","LU0588546209.SGD","GWLLY","LU0327786744.USD","LU1770034418.SGD","LU1023057109.AUD","BK1608","LU0320764599.SGD","BK4588","LU0051755006.USD","LU0052750758.USD","LU0210526637.USD","LU0463099449.HKD","BK1588","LU2097828805.USD","NIO.SI","BK4526","81024","BK4585","601633","LU0708995583.HKD","BK4581","BK1591","09999","LU0326950275.SGD","LU1251922891.USD","LU1303224171.USD","LU2097828631.EUR","BK4532","LU0359202008.SGD","LU1794554557.SGD","LU0140636845.USD","NTES","LU0359201885.HKD","BK4534","LU0359201612.USD","BK1590","LU0244354667.USD","LU0572944931.SGD","LU1719994722.HKD","LU0307460666.USD","LU1720050803.USD","LU0593848301.USD","LU2097828714.EUR","LU1188198961.HKD","LU2097828474.EUR","BK1119","BK4555","BK4548","09995","BK4509","BK4099","02333","LU2097828557.USD","KSTmain","NIO","BK4505","LU0456827905.SGD"],"gpt_icon":1},{"id":"2601003478","title":"港股荣昌生物午后涨近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601003478","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601003478?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:06","pubTimestamp":1767596799,"startTime":"0","endTime":"0","summary":"每经AI快讯,荣昌生物(09995.HK)午后涨近8%,截至发稿涨7.67%,报79.3港元,成交额4.05亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608737829.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608737829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","LU1969619763.USD","09995","LU2148510915.USD","BK0239","LU1064130708.USD","LU1064131003.USD","LU2488822045.USD","688331","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2601080330","title":"港股异动 | 荣昌生物(09995)午后涨近8% 维迪西妥单抗新适应症拟纳入突破性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2601080330","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601080330?lang=zh_cn&edition=full","pubTime":"2026-01-05 14:50","pubTimestamp":1767595850,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,荣昌生物午后涨近8%,截至发稿,涨7.67%,报79.3港元,成交额4.05亿港元。消息面上,2025年12月31日,CDE官网显示,荣昌生物维迪西妥单抗新适应症拟纳入突破性治疗品种,联合曲妥珠单抗及特瑞普利单抗一线治疗HER2高表达的晚期胃/胃食管结合部腺癌。此前维迪西妥单抗已经有3次纳入突破性治疗,若是此次通过公示,将成为该药物的第4次突破性疗法认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09995","LU2328871848.SGD","LU2148510915.USD","688331","BK1583","LU1969619763.USD","LU2488822045.USD","BK1161","BK0239","LU1064130708.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2600032050","title":"每日卖空追踪 | 荣昌生物 01月02日卖空量成交1.3万股,卖空比例为2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600032050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600032050?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342645,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间01月02日,涨2.29%,卖空量成交1.3万股,较上一交易日减少88.39%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163549a4942e33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163549a4942e33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2328871848.SGD","LU1969619763.USD","09995","BK1161","BK1583"],"gpt_icon":0},{"id":"2600059360","title":"跨国药企疯抢中国创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2600059360","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600059360?lang=zh_cn&edition=full","pubTime":"2026-01-02 14:27","pubTimestamp":1767335241,"startTime":"0","endTime":"0","summary":"三生制药、三生国健与辉瑞的合作再度刷新国内药企出海交易首付款金额的最高纪录。6月11日晚,荣昌生物发文称,多位跨国医药公司BD经理主动与荣昌生物接洽,围绕泰它西普的国际合作、技术授权等商业拓展方向开展深度交流。“成本与效果的极致平衡,正成为跨国药企将中国视为核心研发管线来源地的关键逻辑。”BD模式各显其长为适配处于不同发展阶段的企业以及不同的战略目标,我国创新药企的BD交易已形成多种模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102143241a493e43c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102143241a493e43c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1161","BK1574","02162","BK1583","06978","06160","01276","09995"],"gpt_icon":0},{"id":"2595866467","title":"荣昌生物(688331)披露2022年及2023年A股限制性股票激励计划归属条件成就公告,12月29日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595866467","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595866467?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:37","pubTimestamp":1767001039,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘,荣昌生物报收于78.75元,较前一交易日下跌0.48%,最新总市值为443.92亿元。该股当日开盘79.3元,最高80.53元,最低78.5元,成交额达3.38亿元,换手率为2.63%。公司近日发布公告称,第二届董事会第三十三次会议审议通过多项议案。此外,董事会认为2023年A股限制性股票激励计划首次授予第一个归属期的归属条件已达成,同意办理归属,并作废该计划中部分离职激励对象已获授但尚未归属的限制性股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900023766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","BK0239","LU2148510915.USD","399300","09995","LU1064130708.USD","LU1064131003.USD","159982","688331","BK1583","BK1574","LU1969619763.USD","LU2328871848.SGD","BK1161"],"gpt_icon":0},{"id":"2595529587","title":"每日卖空追踪 | 荣昌生物 12月29日卖空量成交3.3万股,卖空比例为1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595529587","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595529587?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:30","pubTimestamp":1766997041,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间12月29日,跌0.66%,卖空量成交3.3万股,较上一交易日减少25%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163632a6dc4c12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229163632a6dc4c12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2328871848.SGD","09995","BK1161","LU1969619763.USD","BK1583"],"gpt_icon":0},{"id":"2594147241","title":"每周股票复盘:荣昌生物(688331)拟回购2000万至4000万元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2594147241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594147241?lang=zh_cn&edition=full","pubTime":"2025-12-28 01:48","pubTimestamp":1766857693,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘,荣昌生物报收于79.13元,较上周的82.4元下跌3.97%。本周,荣昌生物12月22日盘中最高价报82.79元。本周关注点公司公告汇总:荣昌生物计划以集中竞价方式回购股份,金额不低于2000万元且不超过4000万元。公司公告汇总:本次回购股份价格不超过95元/股,期限为董事会审议通过之日起12个月内。本次回购股份拟用于员工持股计划或股权激励,若3年内未使用完毕,未使用部分将注销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2328871848.SGD","LU1969619763.USD","09995","LU2148510915.USD","BK0239","LU1064130708.USD","LU1064131003.USD","LU2488822045.USD","688331","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2594287939","title":"光鲜下的另一面,BD交易后股价不涨反跌成常态?专家:短期热度降低不是坏事","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287939","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594287939?lang=zh_cn&edition=full","pubTime":"2025-12-25 14:21","pubTimestamp":1766643688,"startTime":"0","endTime":"0","summary":"今年创新药企业频繁宣布BD交易,但从三季度以来,原本利好的消息却不被二级市场买账。最近一周,BD交易再掀一个小高潮。12月22日,先声药业(02096.HK)宣布其附属公司江苏再明与Ipsen于12月19日签订独家授权许可协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512253601825588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1997245094.SGD","BK0183","02096","09995","LU0405327494.USD","002755","LU1969619763.USD","01167","LU1997245177.USD","02142","600276","BK1161","BK0196","603087","688062","LU2097828474.EUR","01801","LU2097828631.EUR","000661","BK0028","LU1997244956.HKD","LU2097828557.USD","LU2488822045.USD","LU2097828714.EUR","LU0405327148.USD","LU2495084118.USD","LU2097828805.USD","LU1064131003.USD","LU1146622755.USD","688336","LU1328615791.USD","LU1781817850.SGD","688331","03692","BK1593","BK1589","BK0057","BK0060","LU1064130708.USD","LU2580892862.HKD","BK0012","BK1574","01530","LU2148510915.USD","06978","BK0188","BK0239","LU0502904849.HKD","02509","688428"],"gpt_icon":0},{"id":"2593245061","title":"荣昌生物(09995.HK)涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593245061","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593245061?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:13","pubTimestamp":1766456035,"startTime":"0","endTime":"0","summary":"每经AI快讯,荣昌生物(09995.HK)涨超3%,截至发稿涨3.41%,报78.8港元,成交额9838.12万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233599267548.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599267548.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","LU1969619763.USD","09995","LU2328871848.SGD","LU2488822045.USD","LU2148510915.USD","BK0239","688331","BK1583","LU1064130708.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2593457234","title":"港股异动 | 荣昌生物(09995)涨超3% 自研RC148实现双路径突破 机构看好后续临床潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2593457234","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593457234?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:02","pubTimestamp":1766455373,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,荣昌生物涨超3%,截至发稿,涨3.41%,报78.8港元,成交额9838.12万港元。研究数据显示,RC148单药与联合方案均显示出突出的临床疗效和可控的安全性,实现了双路径突破。目前公司正在积极推进相关临床:根据公司投资者调研纪要,RC148联合治疗一线非小细胞肺癌的II期临床试验已完成患者入组并计划启动联合治疗非小细胞肺癌的Ⅲ期临床研究,看好后续临床潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064130708.USD","BK1161","09995","BK1574","688331","LU1064131003.USD","LU2488822045.USD","LU1969619763.USD","LU2148510915.USD","LU2328871848.SGD","BK1583","BK0239"],"gpt_icon":0},{"id":"2593483499","title":"荣昌生物拟回购 金额2000万元至4000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593483499","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593483499?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:21","pubTimestamp":1766395284,"startTime":"0","endTime":"0","summary":"12月22日,荣昌生物(688331/09995)发布公告,计划以集中竞价交易方式回购股份,回购金额不低于2000万元且不超过4000万元,回购价格上限为95元/股,回购股份将用于员工持股计划或股权激励,回购期限为自董事会审议通过之日起12个月内。2025年前三季度,荣昌生物实现收入17.20亿元,归母净利润-5.51亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512223598357980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","BK1583","LU2148510915.USD","LU1969619763.USD","688331","LU1064130708.USD","LU1064131003.USD","BK0239","LU2328871848.SGD","LU2488822045.USD","09995"],"gpt_icon":0},{"id":"2592044139","title":"医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2592044139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592044139?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:23","pubTimestamp":1766111038,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股集体走高,药明生物 涨5.93%,药明合联涨4.56%,君实生物涨4.54%,康诺亚-B涨4.19%,荣昌生物涨3.98%,科伦博泰生物-B涨4.00%,泰格医药涨4.30%,复宏汉霖涨3.72%,诺诚健华涨3.26%。交银国际发布医药行业周报,展望2026年,该机构认为板块稳中向好态势延续,但影响市场表现的核心因素或呈分化态势,后续选股逻辑或将重回基本面和估值,即关注存在基本面预期差、当前仍被低估的个股。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971870","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","09995","HK0000165453.HKD","LU1969619763.USD","LU1242518857.USD","IE00B0JY6N72.USD","159938","LU1242518931.SGD","BK1161","LU0196878994.USD","LU0052750758.USD","03347","LU0588546209.SGD","09969","02162","LU0359202008.SGD","LU0516422366.SGD","LU0572944931.SGD","LU0327786744.USD","LU2488822045.USD","06990","LU0417516902.SGD","LU0823426308.USD","LU0181495838.USD","BK1521","BK1576","LU0819121731.USD","LU0359201612.USD","SG9999014674.SGD","LU1880383366.USD","SG9999002562.SGD","02696","02268","BK1587","BK1610","LU0708995583.HKD","LU0326950275.SGD","LU0039217434.USD","LU1688375341.USD","02269","LU0823426480.USD","BK1574","LU0417516738.SGD","LU2328871848.SGD","09939","LU0348825331.USD","LU0051755006.USD","LU0348735423.USD","LU0856984785.SGD","01877"],"gpt_icon":0},{"id":"2592903581","title":"荣昌生物:关于取得金融机构股票回购专项贷款承诺函的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2592903581","media":"证券日报","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592903581?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:07","pubTimestamp":1766059669,"startTime":"0","endTime":"0","summary":"证券日报网讯12月18日晚间,荣昌生物发布公告称,近日,公司取得招商银行股份有限公司烟台分行出具的《贷款承诺函》,主要内容如下:1、贷款承诺额度:不超过人民币3600万元且不超过实际回购金额的90%;2、贷款期限:不超过36个月;3、贷款用途:专项用于回购公司股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512183595657981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","LU1064130708.USD","688331","LU2148510915.USD","LU2488822045.USD","BK1574","09995","LU1969619763.USD","BK1161","FISI","LU1064131003.USD","BK1583","LU2328871848.SGD","BK4211"],"gpt_icon":0},{"id":"2592869138","title":"每日卖空追踪 | 荣昌生物 12月18日卖空量成交4.55万股,卖空比例为3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592869138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592869138?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046640,"startTime":"0","endTime":"0","summary":"荣昌生物北京时间12月18日,跌1.03%,卖空量成交4.55万股,较上一交易日减少82.53%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163653a6b1b72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163653a6b1b72b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09995","BK1583","BK1574","LU1969619763.USD","LU2328871848.SGD","BK1161"],"gpt_icon":0},{"id":"2592929145","title":"荣昌生物12月17日主力净流入640.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592929145","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592929145?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:15","pubTimestamp":1765959319,"startTime":"0","endTime":"0","summary":"12月17日, 荣昌生物股价涨1.57%,报收77.50元,成交金额1.5亿元,换手率0.94%,振幅3.74%,量比0.49。荣昌生物今日主力资金净流入640.3万元,上一交易日主力净流出41.9万元。该股近5个交易日上涨0.84%,主力资金累计净流入2379.2万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入324.9万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161625a455fd16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161625a455fd16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2328871848.SGD","09995","LU1969619763.USD","BK1161","BK1574"],"gpt_icon":0},{"id":"2591641505","title":"荣昌生物:第二届董事会第三十二次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2591641505","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591641505?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:05","pubTimestamp":1765803918,"startTime":"0","endTime":"0","summary":"证券日报网讯12月15日晚间,荣昌生物发布公告称,公司第二届董事会第三十二次会议审议通过《关于以集中竞价交易方式回购公司股份方案的议案》等多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512153591974866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688331","BK0239","LU1064130708.USD","09995","BK1161","LU1064131003.USD","BK1583","LU2148510915.USD","LU2328871848.SGD","LU1969619763.USD","LU2488822045.USD","BK1574"],"gpt_icon":0},{"id":"2591054614","title":"荣昌生物(688331.SH)拟以2000万元至4000万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2591054614","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591054614?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:32","pubTimestamp":1765791179,"startTime":"0","endTime":"0","summary":"智通财经APP讯,荣昌生物(688331.SH)发布公告,公司拟以2000万元至4000万元回购股份,回购股份价格不超过95元/股,回购的股份拟用于员工持股计划或股权激励。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","BK1161","09995","BK0239","LU1064131003.USD","LU2488822045.USD","LU1064130708.USD","BK1574","BK1583","LU1969619763.USD","688331","LU2328871848.SGD"],"gpt_icon":0},{"id":"2591691376","title":"恒生医疗保健指数跌幅扩大至2.75% 医药股普遍走低 科伦博泰生物(06990)跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591691376","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591691376?lang=zh_cn&edition=full","pubTime":"2025-12-15 11:11","pubTimestamp":1765768311,"startTime":"0","endTime":"0","summary":"金吾财讯 | 恒生医疗保健指数跌幅扩大至2.75%,医药股普遍走低,科伦博泰生物(06990)跌7.07%,百济神州(06160)跌5.35%,复宏汉霖(02696)跌5.32%,荣昌生物(09995)跌4.05%,康方生物(09926)跌3.61%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971535","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","LU0417516571.SGD","IE00B5MMRT66.SGD","LU1720050803.USD","LU2778985437.USD","LU0417516902.SGD","LU1303224171.USD","BK1515","LU0307460666.USD","LU1794554557.SGD","09939","BK1583","09995","IE00B543WZ88.USD","LU1251922891.USD","LU0348784397.USD","LU2488822045.USD","LU1770034418.SGD","LU1969619763.USD","LU0196878994.USD","LU0348766576.USD","BK1500","LU0540923850.HKD","BK1574","LU0634319403.HKD","LU2476274720.SGD","LU0561508036.HKD","BK1588","BK1161","06160","LU0417516738.SGD","HK0000165453.HKD","LU1719994722.HKD","LU0588546209.SGD","LU1961090484.USD","LU0348767384.USD","LU0348825331.USD","LU2476274308.USD","LU2399975544.HKD","09926","LU0348783233.USD","LU2328871848.SGD","159506","02696","LU0348827113.USD","IE00BPRC5H50.USD","06990","LU0348735423.USD"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1162},{"period":"1month","weight":-0.0809},{"period":"3month","weight":-0.3211},{"period":"6month","weight":0.2697},{"period":"1year","weight":5.1608},{"period":"ytd","weight":0.1278}],"compareEarnings":[{"period":"1week","weight":0.0331},{"period":"1month","weight":0.024},{"period":"3month","weight":-0.0044},{"period":"6month","weight":0.1116},{"period":"1year","weight":0.3567},{"period":"ytd","weight":0.0421}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药(烟台)股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物(ADC)、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.117116},{"month":2,"riseRate":0.8,"avgChangeRate":0.209338},{"month":3,"riseRate":0.4,"avgChangeRate":-0.022811},{"month":4,"riseRate":0.8,"avgChangeRate":0.104301},{"month":5,"riseRate":0.4,"avgChangeRate":-0.023394},{"month":6,"riseRate":0.8,"avgChangeRate":0.127757},{"month":7,"riseRate":0.6,"avgChangeRate":-0.032319},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}